Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Drug–Device Combination Products Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Drug–Device Combination Products Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Infusion Pumps
      • 1.3.3 Orthopedic Combination Products
      • 1.3.4 Photodynamic Therapy Devices
      • 1.3.5 Transdermal Patches
      • 1.3.6 Drug Eluting Stents
      • 1.3.7 Wound Care Products
      • 1.3.8 Inhalers
      • 1.3.9 Other
    • 1.4 Market Segment by Application
      • 1.4.1 Global Drug–Device Combination Products Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Clinic
      • 1.4.4 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Drug–Device Combination Products Production Value 2014-2025
      • 2.1.2 Global Drug–Device Combination Products Production 2014-2025
      • 2.1.3 Global Drug–Device Combination Products Capacity 2014-2025
      • 2.1.4 Global Drug–Device Combination Products Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Drug–Device Combination Products Market Size CAGR of Key Regions
      • 2.2.2 Global Drug–Device Combination Products Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Drug–Device Combination Products Capacity by Manufacturers
      • 3.1.2 Global Drug–Device Combination Products Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Drug–Device Combination Products Revenue by Manufacturers (2014-2019)
      • 3.2.2 Drug–Device Combination Products Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Drug–Device Combination Products Market Concentration Ratio (CR5 and HHI)
    • 3.3 Drug–Device Combination Products Price by Manufacturers
    • 3.4 Key Manufacturers Drug–Device Combination Products Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Drug–Device Combination Products Market
    • 3.6 Key Manufacturers Drug–Device Combination Products Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Infusion Pumps Production and Production Value (2014-2019)
      • 4.1.2 Orthopedic Combination Products Production and Production Value (2014-2019)
      • 4.1.3 Photodynamic Therapy Devices Production and Production Value (2014-2019)
      • 4.1.4 Transdermal Patches Production and Production Value (2014-2019)
      • 4.1.5 Drug Eluting Stents Production and Production Value (2014-2019)
      • 4.1.6 Wound Care Products Production and Production Value (2014-2019)
      • 4.1.7 Inhalers Production and Production Value (2014-2019)
      • 4.1.8 Other Production and Production Value (2014-2019)
    • 4.2 Global Drug–Device Combination Products Production Market Share by Type
    • 4.3 Global Drug–Device Combination Products Production Value Market Share by Type
    • 4.4 Drug–Device Combination Products Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Drug–Device Combination Products Consumption by Application

    6 Production by Regions

    • 6.1 Global Drug–Device Combination Products Production (History Data) by Regions 2014-2019
    • 6.2 Global Drug–Device Combination Products Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Drug–Device Combination Products Production Growth Rate 2014-2019
      • 6.3.2 United States Drug–Device Combination Products Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Drug–Device Combination Products Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Drug–Device Combination Products Production Growth Rate 2014-2019
      • 6.4.2 European Union Drug–Device Combination Products Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Drug–Device Combination Products Import & Export
    • 6.5 China
      • 6.5.1 China Drug–Device Combination Products Production Growth Rate 2014-2019
      • 6.5.2 China Drug–Device Combination Products Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Drug–Device Combination Products Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Drug–Device Combination Products Consumption by Regions

    • 7.1 Global Drug–Device Combination Products Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Drug–Device Combination Products Consumption by Type
      • 7.2.2 United States Drug–Device Combination Products Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Drug–Device Combination Products Consumption by Type
      • 7.3.2 European Union Drug–Device Combination Products Consumption by Application
    • 7.4 China
      • 7.4.1 China Drug–Device Combination Products Consumption by Type
      • 7.4.2 China Drug–Device Combination Products Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Drug–Device Combination Products Consumption by Type
      • 7.5.2 Rest of World Drug–Device Combination Products Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Abbott
      • 8.1.1 Abbott Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Drug–Device Combination Products
      • 8.1.4 Drug–Device Combination Products Product Introduction
      • 8.1.5 Abbott Recent Development
    • 8.2 Terumo Corporation
      • 8.2.1 Terumo Corporation Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Drug–Device Combination Products
      • 8.2.4 Drug–Device Combination Products Product Introduction
      • 8.2.5 Terumo Corporation Recent Development
    • 8.3 Stryker Corporation
      • 8.3.1 Stryker Corporation Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Drug–Device Combination Products
      • 8.3.4 Drug–Device Combination Products Product Introduction
      • 8.3.5 Stryker Corporation Recent Development
    • 8.4 Mylan
      • 8.4.1 Mylan Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Drug–Device Combination Products
      • 8.4.4 Drug–Device Combination Products Product Introduction
      • 8.4.5 Mylan Recent Development
    • 8.5 Medtronic
      • 8.5.1 Medtronic Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Drug–Device Combination Products
      • 8.5.4 Drug–Device Combination Products Product Introduction
      • 8.5.5 Medtronic Recent Development
    • 8.6 Allergan
      • 8.6.1 Allergan Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Drug–Device Combination Products
      • 8.6.4 Drug–Device Combination Products Product Introduction
      • 8.6.5 Allergan Recent Development
    • 8.7 Boston Scientific
      • 8.7.1 Boston Scientific Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Drug–Device Combination Products
      • 8.7.4 Drug–Device Combination Products Product Introduction
      • 8.7.5 Boston Scientific Recent Development
    • 8.8 Novartis
      • 8.8.1 Novartis Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Drug–Device Combination Products
      • 8.8.4 Drug–Device Combination Products Product Introduction
      • 8.8.5 Novartis Recent Development
    • 8.9 C.R. Bard
      • 8.9.1 C.R. Bard Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Drug–Device Combination Products
      • 8.9.4 Drug–Device Combination Products Product Introduction
      • 8.9.5 C.R. Bard Recent Development
    • 8.10 Teleflex Incorporated
      • 8.10.1 Teleflex Incorporated Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Drug–Device Combination Products
      • 8.10.4 Drug–Device Combination Products Product Introduction
      • 8.10.5 Teleflex Incorporated Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Drug–Device Combination Products Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Drug–Device Combination Products Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Drug–Device Combination Products Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Drug–Device Combination Products Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Drug–Device Combination Products Production Forecast by Type
      • 9.7.2 Global Drug–Device Combination Products Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Drug–Device Combination Products Sales Channels
      • 10.2.2 Drug–Device Combination Products Distributors
    • 10.3 Drug–Device Combination Products Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Combination products are therapeutic and diagnostic products that combine drugs, devices, and/or biological products. 
      In 2019, the market size of Drug–Device Combination Products is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drug–Device Combination Products.

      This report studies the global market size of Drug–Device Combination Products, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Drug–Device Combination Products production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Abbott
      Terumo Corporation
      Stryker Corporation
      Mylan
      Medtronic
      Allergan
      Boston Scientific
      Novartis
      C.R. Bard
      Teleflex Incorporated

      Market Segment by Product Type
      Infusion Pumps
      Orthopedic Combination Products
      Photodynamic Therapy Devices
      Transdermal Patches
      Drug Eluting Stents
      Wound Care Products
      Inhalers
      Other

      Market Segment by Application
      Hospital
      Clinic
      Other

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Drug–Device Combination Products status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Drug–Device Combination Products manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Drug–Device Combination Products are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now